Charles Ballantyne — CFO

Get alerts when Charles Ballantyne trades

Alerts for a single person aren't available yet, so you'll follow the companies where they're an insider: Hansa Biopharma AB.

12-month summary

Net buyer over the last 12 months

1 open-market buy, 0 sales, 0 share awards · USD 70,853.50 bought, USD 0.00 sold

Roles

Hansa Biopharma AB Stockholm
CFO
07.11.2025 – 07.11.2025

Transactions (including via associated entities)

DateIssuerTransaction typeVolumePriceValueSource
07.11.2025Hansa Biopharma AB Stockholm
Bought — open marketAcquisition
25,000USD 2.83
USD 70,853.50
↗